The Epstein-Barr Virus-induced Ca2+/calmodulin-dependent Kinase Type IV/Gr Promotes a Ca(2+)-dependent Switch from Latency to Viral Replication

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1997 Sep 1

PMID 9261377

Citations 15

Authors

T Chatila

N Ho

P Liu

S Liu

G Mosialos

E Kieff

S H Speck

Affiliations

Soon will be listed here.

Abstract

The switch from latency to viral replication in Epstein-Barr virus (EBV)-transformed human B cells is mediated by Zta, the protein product of immediate-early EBV gene BZLF1. BZLF1 transcription is normally suppressed in EBV-transformed B cells but can be induced in some cell lines upon ligation of surface immunoglobulin by mechanisms that include the activation of Ca(2+)-dependent signaling pathways. The multifunctional Ca2+/calmodulin-dependent kinase type IV/Gr (CaMKIV/Gr) is normally absent in primary human B cells, but its expression is induced by the EBV oncoprotein LMP1 in the course of B-cell growth transformation by EBV. In this study, we demonstrate that activated CaMKIV/Gr induces transcription from the BZLF1 promoter and upregulates the expression of Zta in permissive cells. Transcriptional activation of the BZLF1 promoter by CaMKIV/Gr is dependent on the CREB/AP1 binding element ZII and is greatly augmented by the Ca2+/calmodulin-dependent phosphatase calcineurin. These results outline a virus-regulated mechanism involving CaMKIV/Gr which promotes transition from latency to productive viral replication in response to Ca(2+)-mobilizing extracellular signals.

Citing Articles

Endoplasmic reticulum & mitochondrial calcium homeostasis: The interplay with viruses.

Panda S, Behera S, Alam M, Syed G Mitochondrion. 2021; 58:227-242.

PMID: 33775873 PMC: 7612732. DOI: 10.1016/j.mito.2021.03.008.

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

Romero-Masters J, Huebner S, Ohashi M, Bristol J, Benner B, Barlow E PLoS Pathog. 2020; 16(2):e1008365.

PMID: 32059024 PMC: 7046292. DOI: 10.1371/journal.ppat.1008365.

Calcium mobilization is responsible for Thapsigargin induced Epstein Barr virus lytic reactivation in immortalized lymphoblstoid cell lines.

Hoji A, Xu S, Bilben H, Rowe D Heliyon. 2018; 4(11):e00917.

PMID: 30480154 PMC: 6240808. DOI: 10.1016/j.heliyon.2018.e00917.

Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca/calpain/ITGβ4 axis.

Liang J, Zheng S, Xiao X, Wei J, Zhang Z, Ernberg I Biol Open. 2017; 6(6):914-922.

PMID: 28512118 PMC: 5483025. DOI: 10.1242/bio.024646.

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency.

Yu X, McCarthy P, Lim H, Iempridee T, Kraus R, Gorlen D J Virol. 2011; 85(10):5081-90.

PMID: 21389123 PMC: 3126197. DOI: 10.1128/JVI.02615-10.

References

Lieberman P, Hardwick J, Sample J, Hayward G, Hayward S . The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol. 1990; 64(3):1143-55. PMC: 249228. DOI: 10.1128/JVI.64.3.1143-1155.1990. View

Liu S, Liu P, Borras A, Chatila T, Speck S . Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 1997; 16(1):143-53. PMC: 1169621. DOI: 10.1093/emboj/16.1.143. View

Flemington E, Speck S . Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 1990; 64(3):1227-32. PMC: 249237. DOI: 10.1128/JVI.64.3.1227-1232.1990. View

Lieberman P, Berk A . In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J Virol. 1990; 64(6):2560-8. PMC: 249432. DOI: 10.1128/JVI.64.6.2560-2568.1990. View

Chang Y, Dong D, Hayward G, Hayward S . The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J Virol. 1990; 64(7):3358-69. PMC: 249580. DOI: 10.1128/JVI.64.7.3358-3369.1990. View

Kincaid R, Giri P, Higuchi S, Tamura J, Dixon S, Marietta C . Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J Biol Chem. 1990; 265(19):11312-9. View

Flemington E, Speck S . Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc Natl Acad Sci U S A. 1990; 87(23):9459-63. PMC: 55185. DOI: 10.1073/pnas.87.23.9459. View

Kouzarides T, Packham G, Cook A, Farrell P . The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene. 1991; 6(2):195-204. View

Sheng M, Thompson M, Greenberg M . CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 1991; 252(5011):1427-30. DOI: 10.1126/science.1646483. View

10.

zur Hausen H, ONEILL F, Freese U, Hecker E . Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 1978; 272(5651):373-5. DOI: 10.1038/272373a0. View

11.

Bauer G, Hofler P, zur Hausen H . Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers. Virology. 1982; 121(1):184-94. DOI: 10.1016/0042-6822(82)90128-3. View

12.

Hummel M, Kieff E . Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. Proc Natl Acad Sci U S A. 1982; 79(18):5698-702. PMC: 346972. DOI: 10.1073/pnas.79.18.5698. View

13.

Miller G, RABSON M, Heston L . Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol. 1984; 50(1):174-82. PMC: 255597. DOI: 10.1128/JVI.50.1.174-182.1984. View

14.

Cohen L, Speck S, Roberts B, Strominger J . Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc Natl Acad Sci U S A. 1984; 81(13):4183-7. PMC: 345393. DOI: 10.1073/pnas.81.13.4183. View

15.

Baer R, Bankier A, Biggin M, Deininger P, Farrell P, Gibson T . DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984; 310(5974):207-11. DOI: 10.1038/310207a0. View

16.

Countryman J, Miller G . Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A. 1985; 82(12):4085-9. PMC: 397939. DOI: 10.1073/pnas.82.12.4085. View

17.

Takada K, Shimizu N, Sakuma S, Ono Y . trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol. 1986; 57(3):1016-22. PMC: 252835. DOI: 10.1128/JVI.57.3.1016-1022.1986. View

18.

Faggioni A, Zompetta C, Grimaldi S, Barile G, Frati L, Lazdins J . Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science. 1986; 232(4757):1554-6. DOI: 10.1126/science.3012779. View

19.

Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A . Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 1986; 5(12):3243-9. PMC: 1167318. DOI: 10.1002/j.1460-2075.1986.tb04635.x. View

20.

DE Wet J, Wood K, DeLuca M, Helinski D, Subramani S . Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987; 7(2):725-37. PMC: 365129. DOI: 10.1128/mcb.7.2.725-737.1987. View